DrugPatentWatch Database Preview
VEINAMINE 8% Drug Profile
When do Veinamine 8% patents expire, and when can generic versions of Veinamine 8% launch?
Veinamine 8% is a drug marketed by Hospira Inc and is included in one NDA.
The generic ingredient in VEINAMINE 8% is amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate profile page.
Summary for VEINAMINE 8%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | VEINAMINE 8% at DailyMed |
US Patents and Regulatory Information for VEINAMINE 8%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira Inc | VEINAMINE 8% | amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate | INJECTABLE;INJECTION | 017957-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
